Cytecare Hospitals
Cytecare Hospitals specializes in the fields of gynecological, Haemato-Oncology, radiotherapy, GI, and hepatobiliary.
- Company typePrivate
- Founded2014
- HeadquartersBengaluru, India
- Headcount251–500
- GTM typeB2C
- OfferingServices
What Cytecare Hospitals does
Cytecare Hospitals is a hospital and healthcare company that specializes in the fields of gynecological, Haemato-Oncology, radiotherapy, GI, and hepatobiliary. The company delivers personalized cancer care to patients tailored to meet their unique requirements.
Cytecare Hospitals firmographics
Firmographics- Name
- Cytecare Hospitals
- Legal name
- Cytecare Hospitals Pvt. Ltd
- Website
- https://www.cytecare.com/
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Cytecare Hospitals specializes in the fields of gynecological, Haemato-Oncology, radiotherapy, GI, and hepatobiliary.
- Ownership category
- akta.pro rank
Where Cytecare Hospitals is headquartered
LocationHeadquarters
- HQ city
- Bengaluru
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Cytecare Hospitals business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Hospital Healthcare Services: Revenue generated from comprehensive healthcare services including consultations, diagnostics, treatments, surgeries, hospitalizations, and follow-up care across oncology and multiple medical specialties
- Diagnostic Services: Revenue from advanced diagnostic imaging including PET CT, radiology, pathology, nuclear medicine, and specialized cancer screening packages
- Cancer Treatment Procedures: Revenue from surgical procedures, chemotherapy, radiation therapy, bone marrow transplants, and advanced treatments like CAR-T cell therapy
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Cytecare Hospitals product offering
Product offeringCore offering
Cytecare Hospitals operates a 150-bed cancer treatment center in Bangalore delivering organ-site-focused oncology care from screening through survivorship. Core offerings span medical oncology (16-bed chemotherapy daycare), radiation oncology, surgical oncology, advanced cellular therapies (CAR-T, stem cell, gene therapy, immunotherapy), bone marrow transplantation, and multi-specialty diagnostics including PET CT, radiology, pathology, and nuclear medicine. Revenue is generated from consultations, inpatient hospitalizations, surgical procedures, chemotherapy, radiation therapy, and specialized cancer treatment programs.
Product overview
Cytecare Hospitals is a 150-bed advanced oncology hospital in Bangalore, India offering a comprehensive cancer care ecosystem. The core Oncology Center of Excellence provides organ-site-focused cancer treatment including medical oncology (16-bed chemotherapy center), radiation oncology, surgical oncology, and advanced therapies such as CAR-T Cell Therapy (Karnataka's first), stem cell therapy, gene therapy, and immunotherapy. The hospital operates specialized cancer treatment programs for breast, gastrointestinal, head and neck, gynecological, brain, pediatric, uro-oncology, and haemato-oncology cancers. Diagnostic capabilities include advanced PET CT imaging (GE Discovery IQ), radiology, pathology, biopsy, endoscopy, and nuclear medicine. Support services encompass psycho-oncology, onco-nutrition, patient navigators, pain and palliative care, and blood transfusion services. The hospital also offers comprehensive health screening packages for individuals Above and Below 40 years, operates the Cytecare Centre for Breast Care (a dedicated multidisciplinary breast health facility), and provides fellowship programs in head & neck cancer surgery, breast cancer diseases, palliative care, tumour pathology, and onco-anaesthesia. Educational initiatives include the Cancon conference series and clinical trial participation. The Saahasa community program supports cancer patients and survivors.
Differentiator
Problem solved
Functional benefit
Brands
- Saahasa: A community program for cancer patients, survivors, and caregivers that provides support and resources for cancer prevention and mitigation.
- Cancon
Products and services
- Oncology Center of Excellence Advanced organ-site-focused cancer care and treatment center with a multidisciplinary team of super-specialists and researched cancer care practitioners guided by national and global protocols.
- Cancer Screening Packages (Below 40 and Above 40) Age-specific cancer screening packages providing comprehensive health check-ups and early cancer detection services for individuals Below 40 and Above 40 years of age.
- Comprehensive Health Packages (Below 40 and Above 40) Age-specific comprehensive health screening packages for individuals Below 40 and Above 40 years providing deeper insights into health with advanced diagnostics.
- Medical Oncology 16-bedded daycare chemotherapy center providing cancer treatment through chemotherapy protocols.
- Radiation Oncology Precise radiation treatments delivered by expert radiation oncologists for cancer patients.
- Surgical Oncology Advanced surgical procedures for various cancer types including breast, gastrointestinal, gynecological, head and neck, and other cancers, leveraging AI and robotics-assisted surgical systems.
- CAR-T Cell Therapy Advanced immunotherapy that harnesses immune cells to fight cancer, offering hope beyond conventional treatments; Karnataka's first hospital to offer this therapy.
- Bone Marrow Transplant Specialized bone marrow transplantation services for blood and lymphatic system related cancers.
- PET CT Imaging (Nuclear Medicine) State-of-the-art GE Discovery IQ 3 Ring 16-slice PET with LightBurst technology providing advanced diagnostic imaging with reduced scan time and superior scan quality.
- Stem Cell Therapy Revolutionary medical technique using stem cells to repair and regenerate damaged tissues, applied as part of oncology care.
- Gene Therapy Precision treatment that enhances therapy by modifying genetic material for targeted disease intervention in cancer care.
- Immunotherapy Cancer treatment that utilizes the body's immune defenses to fight cancer, transforming treatment approaches at Cytecare.
- Pain and Palliative Care Follow-up care and post-treatment management for cancer patients focusing on quality of life.
- Cytecare Centre for Breast Care Dedicated multidisciplinary facility in Bengaluru offering coordinated breast health and breast cancer care services from prevention and screening through diagnosis, treatment, rehabilitation, and survivorship support, featuring 3D Digital Breast Tomosynthesis.
- Organ-site Cancer Treatment Programs Specialized multidisciplinary cancer treatment programs across breast, gastrointestinal, gynecological, head and neck, brain, pediatric, uro-oncology, neuro-oncology, and haemato-oncology, organized by tumor site.
- Specialty Outpatient Clinics Multi-specialty outpatient clinics including Prostate, Diabetes, COPD, Liver, Fever & Infectious Diseases, Gastro & Liver, Tobacco Cessation, Gynaec Screening, Nutrition, and Kidney Screening clinics.
- Diagnostic Services Comprehensive cancer diagnostic services spanning Radiology, Pathology, Biopsy, Endoscopy, Colposcopy Clinic & Pre-Cancerous Lesion Treatment.
- Psycho-Oncology Support Psychological support services for cancer patients and their families throughout the treatment journey.
- Onco-Nutrition Support Nutritional counseling and support for cancer patients during treatment.
- Patient Navigator Services Guided support helping patients navigate through their cancer treatment journey.
- International Patient Services Dedicated services for international patients including medical visa assistance, travel coordination, interpreter services, and treatment planning for patients from 13+ countries.
Quantifiable outcome
- Rank 1 Best Oncology Hospital in Bengaluru
- +3 more outcomes
Companies that use Cytecare Hospitals
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Cytecare Hospitals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Cytecare Hospitals partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor and core.
- IMA (Indian Medical Association) and WDWminorCytecare partnered with IMA and WDW to organize a cancer awareness walkathon at Allalasandra Lake, Yelahanka on 14th February 2025, promoting community health awareness and cancer prevention education.
- HumanistcoreLaunched Humanist-Cytecare Institute for Dialysis and Renal Diseases in September 2023, providing comprehensive kidney care services including dialysis treatments and renal disease management. Multiple media reports covered the launch across regional and national publications.
- Bugworks Research Inc.coreBugworks Research launched a cancer research laboratory at Cytecare Hospitals in October 2022 to accelerate immuno-oncology research. The collaboration focuses on developing new cancer treatments and advancing clinical research capabilities, combining Bugworks' research expertise with Cytecare's clinical infrastructure.
- Brains Neuro Spine HospitalcoreCytecare and Brains Neuro Spine Hospital collaborated to launch a Neurosciences Centre, combining expertise in neuroscience and oncology to provide comprehensive care for brain and nervous system cancers and conditions.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Cytecare Hospitals competitors and assessment
Company assessmentDirect peers
- Healthcare Global Enterprises (HCG): India's largest dedicated oncology hospital chain, headquartered in Bangalore. HCG operates a similar specialty cancer hospital model with multiple centers across India, directly competing with Cytecare in advanced oncology treatments and Bangalore catchment.
- Omega Hospitals: Morgan Stanley PE-backed oncology chain that acquired majority stake in Cytecare. Omega is now the parent entity and direct operating peer, with multiple cancer specialty centers across India.
- American Oncology Institute (AOI): India-focused dedicated oncology hospital chain operating multiple cancer centers. AOI offers similar specialty cancer care positioning and competes for both domestic and medical tourism patients seeking advanced oncology treatments.
Broad incumbents
- Apollo Hospitals (Cancer Care): One of India's largest hospital chains with a significant oncology program across multiple cities. Apollo offers comprehensive cancer care including medical, surgical, and radiation oncology, competing with Cytecare for complex oncology cases though within a much broader multi-specialty portfolio.
- Fortis Healthcare: Major Indian multi-specialty hospital chain with oncology offerings across its network. Fortis competes for cancer patients in Bangalore and other metros, with broader service lines but less oncology specialization than Cytecare.
- Manipal Hospitals: Leading Bangalore-based multi-specialty hospital group with comprehensive oncology services. Manipal is a direct Bangalore competitor to Cytecare for cancer patients and offers the advantage of broader multi-specialty integration.
- Tata Memorial Hospital (TMC): India's premier government-run cancer hospital in Mumbai. TMC is a major referral destination for complex oncology cases and competes with Cytecare for advanced treatment patients, though primarily serves government-subsidized patients.
- Max Healthcare: Large North India-focused hospital chain with significant oncology programs. Max competes for advanced oncology patients from across India and internationally, with strong medical oncology and bone marrow transplant capabilities.
- Narayana Health (Mazumdar Shaw Cancer Centre): Major Indian hospital chain with a specialized cancer center in Bangalore. Narayana Health's Mazumdar Shaw Cancer Centre is a direct Bangalore-based oncology competitor with strong reputation in complex cancer surgeries.
Regional players
- Basavatarakam Indo American Cancer Hospital: Hyderabad-based specialty cancer hospital offering comprehensive oncology services. While serving a different geography, it competes for international medical tourism patients and represents a comparable specialty cancer hospital model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key highlights7 records
Customer concentration
Cytecare Hospitals social profiles
Digital presenceCytecare Hospitals compliance and trust
Trust signalCompliance5 records
Cytecare Hospitals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cytecare Hospitals leadership team
Management profileNumber of profiles
Profiles9 records
Cytecare Hospitals funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cytecare Hospitals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cytecare Hospitals
What does Cytecare Hospitals do?
Cytecare Hospitals operates a 150-bed cancer treatment center in Bangalore delivering organ-site-focused oncology care from screening through survivorship. Core offerings span medical oncology (16-bed chemotherapy daycare), radiation oncology, surgical oncology, advanced cellular therapies (CAR-T, stem cell, gene therapy, immunotherapy), bone marrow transplantation, and multi-specialty diagnostics including PET CT, radiology, pathology, and nuclear medicine. Revenue is generated from consultations, inpatient hospitalizations, surgical procedures, chemotherapy, radiation therapy, and specialized cancer treatment programs.
Is Cytecare Hospitals a public or private company?
Cytecare Hospitals is a private company. It is classified as private equity controlled and is currently operating.
When was Cytecare Hospitals founded?
Cytecare Hospitals was founded in 2014. It employs 251 to 500 people.
Where is Cytecare Hospitals based?
Cytecare Hospitals is headquartered in Bengaluru, India, in the Asia region.
How does Cytecare Hospitals make money?
Three revenue lines are on record. Hospital Healthcare Services are the primary driver. The others are diagnostic Services and cancer Treatment Procedures.
Who are Cytecare Hospitals's main competitors?
Direct peers on record are Healthcare Global Enterprises (HCG), Omega Hospitals and American Oncology Institute (AOI). Broad incumbents are Apollo Hospitals (Cancer Care), Fortis Healthcare, Manipal Hospitals, Tata Memorial Hospital (TMC), Max Healthcare and Narayana Health (Mazumdar Shaw Cancer Centre). Basavatarakam Indo American Cancer Hospital is listed as a regional player.
Does Cytecare Hospitals have an API?
No public API is recorded for Cytecare Hospitals.